Targeting 5-Hydroxytryptamine receptor 1A in portal vein to decrease portal hypertension.
Zhu CP, Liu SQ, Wang KQ, Xiong HL, Aristu-Zabalza P, Boyer-Díaz Z, Feng JF, Song SH, Luo C, Chen WS, Zhang X, Dong WH, Gracia-Sancho J, Xie WF.
Zhu CP, et al. Among authors: xie wf.
Gastroenterology. 2024 Jun 19:S0016-5085(24)05062-5. doi: 10.1053/j.gastro.2024.06.007. Online ahead of print.
Gastroenterology. 2024.
PMID: 38906512